One of the leading pharmaceutical companies in country, ACME Laboratories Ltd launches three new drugs for harnessing diabetes which are to be ingested in six separate doses.
The announcement was made for marketing the drugs named Omari, Imegli and Glifo during a spectacular programme titled “Diabetes Unbound: Unveiling Tomorrow’s Triumph Over Diabetes” held at the Samson H Chowdhury Centre in the capital, read a press release on Monday.
The Chairman of the National Diabetic Association Professor A K Azad Khan presided over the event as the chief guest. Besides a whole host of coveted physicians were also present at the occasion.
“The drug called Omari will be affordable for all and the introduction of Imegli has paved the leeway for research in treating Type 2 diabetes,” A K Azad said.
Most patients suffering from Type 2 diabetes fail to subdue the ailment. That is where the three drugs namely Omari, Imegli and Glifo come in, to regulate glucose levels in the bloodstream, develop insulin and improve the beta cell and mitochondrial function.
The drugs revolutionised the treatment of an ailment as complicated as diabetes. The drug Omari is the first of its kind that is to be ingested once every week.
